Medical Health Cluster


Paxlovid Reduces Risk of COVID Death by 79% in Older Adults: Study

The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients who are ages 65 and older, according to a new study published in The New England Journal of Medicine. The pill, which is a combination of the drugs nirmatrelvir and ritonavir, […]

Read More

Paxlovid Expiration Dates Extended

Expiration dates have been extended from 9 months after manufacture to 12 months for 4 lots of the COVID-19 antiviral therapy Paxlovid, which consists of copackaged nirmatrelvir tablets and ritonavir tablets. The lot numbers and original expiration dates are listed on the FDA website. The nirmatrelvir-ritonavir lots were manufactured before the FDA […]

Read More

Worldwide access to Paxlovid remains inequitable

In a Think Global Health article, IHME staff examine the barriers to acquiring the antiviral Paxlovid, which can greatly reduce the chance of COVID-19 hospitalizations and deaths. Low- and middle-income nations must contend with licensing dilemmas, lack of supplies, and high costs to gain access to Paxlovid. “This would be similar to the […]

Read More

México recibe 180 mil tratamientos de Paxlovid contra el COVID

México recibió los primeros 180 mil tratamientos de Paxlovid, un medicamento para tratar el COVID-19. La Secretaría de Salud informó el miércoles que estos medicamentos serán suministrados sin costo a personas con salud vulnerable. “El Paxlovid impide que el SARS-CoV-2 pueda replicarse, por lo que es recomendado para personas con cuadro leve o moderado de COVID-19 con alto […]

Read More

The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid

David Ho, MD, managed to avoid contracting COVID-19 for more than 2 years. But SARS-CoV-2 finally got the best of the pioneering HIV researcher on an April trip to Paris for, of all things, a 2-day COVID-19 conference. The irony is not lost on Ho, director of the Aaron Diamond […]

Read More